Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report  
Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 11/18 04:49:40 am
3577 ILa   +0.99%
11/16Johnson & Johnson Opioid Verdict Cut -- WSJ
DJ
11/15Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million
RE
11/15Johnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 Million
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on TEVA PHARMACEUTICAL INDUST
02/07/20 FY 2019 Earnings Release (Projected)
04/30/20 Q1 2020 Earnings Release (Projected)
07/30/20 Interim 2020 Earnings Release (Projected)
10/29/20 Q3 2020 Earnings Release (Projected)
Past events on TEVA PHARMACEUTICAL INDUST
11/07/19 | 08:00am Q3 2019 Earnings Call
11/07/19 | 07:00am Q3 2019 Earnings Release
10/30/19 | 12:30am World Neurology Congress - Poster - WCN19-1380
10/30/19 | 12:30am World Neurology Congress - Poster - WCN19-1351
Upcoming sector events for TEVA PHARMACEUTICAL INDUST
11/18/19 CSPC PHARMACEUTICAL GROUP LIMITED : Q3 2019 Earnings Release
11/18/19 | 08:00pm BEIJING TONGRENTANG CO., LTD : Extraordinary Shareholders Meeting
11/19/19 | 07:00am H. LUNDBECK A/S : Investor Meeting
11/19/19 | 10:50am CATALENT, INC. : PEGS Europe Conference
More events
Past sector events for TEVA PHARMACEUTICAL INDUST
11/14/19 | 12:30pm TAKEDA PHARMACEUTICAL COMPANY LIMITED : R&D Day
11/15/19 VIFOR PHARMA AG : Credit Suisse Swiss Small & Mid Cap Conference
11/15/19 | 11:15am TAKEDA PHARMACEUTICAL COMPANY LIMITED : Investor Meeting - Plasma-Derived Therapies Day
11/17/19 | 09:30pm CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD. : Extraordinary Shareholders Meeting
Annual publications
Annual results2016201720182019 (e)2020 (e)2021 (e)
Sales
M $
Released
Forecast
Spread
21 903
21 716
0,86%
22 385
22 146
1,1%
18 854
18 779
0,40%

17 248

17 102

17 183
Operating income
(EBITDA)
M $
Released
Forecast
Spread
7 300
7 362
-0,84%
6 700
6 498
3,1%
5 319
5 442
-2,3%

4 674

4 712

4 917
Operating profit
(EBIT)
M $
Released
Forecast
Spread
6 847
6 904
-0,83%
6 073
5 927
2,5%
4 723
4 672
1,1%

4 100

4 179

4 291
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
824
3 459
-76%
-18 379
-4 549
-304%
-2 596
1 123
-331%

273

3 101

3 421
Net income
M $
Released
Forecast
Spread
68,0
2 463
-97%
-16 525
-4 399
-276%
-2 399
673
-456%

23,0

1 913

2 032
EPS
 $
Released
Forecast
Spread
0,07
2,07
-97%
-16,3
-3,85
-323%
-2,35
0,68
-448%

-0,59

1,49

1,76
Announcement Date02/13/201702/08/201802/13/2019

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise